Which of these is an FDA approved indication for use of modafinil as an adjunct ?
## **Core Concept**
Modafinil is a wakefulness-promoting agent used for the treatment of disorders such as narcolepsy, shift work sleep disorder, and excessive daytime sleepiness associated with obstructive sleep apnea. It works by influencing various neurotransmitter systems in the brain, including dopamine, norepinephrine, and GABA, although its exact mechanism of action is not fully understood.
## **Why the Correct Answer is Right**
The correct answer, , refers to the use of modafinil as an adjunct to treat excessive daytime sleepiness associated with obstructive sleep apnea (OSA), narcolepsy, and shift work sleep disorder (SWSD). Specifically, one of its notable FDA-approved indications as an adjunct is for the treatment of excessive daytime sleepiness in patients with OSA who have not had an adequate response to continuous positive airway pressure (CPAP) therapy. This makes it a valuable treatment option for patients who experience residual daytime sleepiness despite standard treatments for their sleep disorders.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, although modafinil may have off-label uses or be investigated for various conditions, its primary and well-established FDA-approved indications do not include this choice.
- **Option B:** Similarly, this option is not a recognized FDA-approved indication for modafinil as an adjunct.
- **Option C:** This option might seem plausible but does not accurately reflect a primary FDA-approved indication for modafinil.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that modafinil is often used off-label for conditions like attention deficit hyperactivity disorder (ADHD) and depression, but its established FDA-approved indications include treatment of excessive daytime sleepiness associated with narcolepsy, OSA, and SWSD. Clinicians should be aware of these distinctions to ensure appropriate prescribing practices.
## **Correct Answer:** . Excessive daytime sleepiness associated with obstructive sleep apnea.